Showing 3471-3480 of 18631 results for "".
A Clinician's Guide to the ACIP Travel Vaccination Recommendations
https://reachmd.com/programs/vaccination/a-clinicians-guide-to-the-acip-travel-vaccination-recommendations/26483/Get ready to integrate the latest ACIP updates into practice to improve patient care and public health outcomes with this essential recap.Alloimmune Thrombocytopenia in the Fetus and Newborn
https://reachmd.com/programs/cme/alloimmune-thrombocytopenia-in-the-fetus-and-newborn/13909/In severe cases, FNAIT can lead to fetal intracranial hemorrhage. How can you lower risks for your patients facing this uncommon disorder?Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
https://reachmd.com/programs/cme/expert-perspectives-from-aua-2025-contextualizing-the-evolving-landscape-of-bladder-cancer/33076/Explore expert insights from AUA 2025 on advancing bladder cancer care, with updates on NMIBC treatment and biomarker-driven strategies.From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
https://reachmd.com/programs/cme/from-late-line-rescue-to-early-line-option-the-potential-for-bispecific-antibodies-in-multiple-myeloma/49264/Explore how bispecific antibodies are moving earlier in the treatment paradigm of multiple myeloma, supported by pivotal data showing improved patient outcomes.Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
https://reachmd.com/programs/cme/distinguishing-first-line-treatment-adverse-event-profiles-in-her2-negative-upper-gi-cancers/37691/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingWhy CELMoDs Matter in Myeloma
https://reachmd.com/programs/cme/why-celmods-matter-in-myeloma/36558/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma Activity- Lighting the Way: Exploring the Potential of Photobiomodulation for Dry AMD Treatmenthttps://reachmd.com/programs/cme/Lighting-the-Way-Exploring-the-Potential-of-Photobiomodulation-for-Dry-AMD-Treatment-2512/33041/Learn about multiwavelength PBM for the treatment of dry AMD, including the MOA, administration, eff
Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
https://reachmd.com/programs/cme/case-application-unlocking-relapsedrefractory-myeloma-with-celmods/36574/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivityBreaking Barriers in AML: Risk Stratification, Molecular Profiling, and Novel Menin-Directed Treatment Options
https://reachmd.com/programs/cme/breaking-barriers-in-aml-risk-stratification-molecular-profiling-and-novel-menin-directed-treatment-options/33175/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Collaborative Care: Managing ADC-Related Ocular Toxicities
https://evolvemeded.com/specialty/optometry/specialty-optometry-managing-adc-related-2421/32366/Primary eye care and oncology experts discuss the importance of collaboration to manage ocular toxicities caused by oncology medications.